9th Annual Biomarkers Congress

Drug Design: University of Texas, MD Anderson

Total Score People Score Events Score
62 54 28
Date Event Presentation Speakers
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Therapy of Cancer Metastasis: Attacking the Stroma Isaiah J. Fidler
The Biology of Cancer Metastasis Isaiah J. Fidler
July 11, 2010 Translational Cancer Medicine 2010 (USA) Toward personalized therapy for advanced non-small cell lung cancer: The M. D. Anderson BATTLE Programs Roy S. Herbst
May 19, 2010 Engineering Antibodies A Computational-Experimental Strategy for the Isolation of Antigen-Specific Antibodies from Immunized Animals George Georgiou
Chairperson’s Opening Remarks George Georgiou
In vitro screening or immunization? Isolating biologically active antibodies George Georgiou
January 22, 2010 2010 Gastrointestinal Cancers Symposium Surgical Oncologist Roderich Schwarz
Is There Resistance to Anti-angiogenic Agents? Lee M Ellis
GI Cancer Stem Cells: Bench to Bedside Jaffer A. Ajani
Medical Oncologist Gauri Varadhachary
Chemoprevention: Who Can Benefit? Robert S Bresalier
Primer in Cancer Genetics Miguel Rodriguez-Bigas
General Session IX: Cancers of the Colon and Rectum: Multidisciplinary Treatment Cathy Eng
Angiogenesis Inhibition and Its Impact on Future Adjuvant Studies and Advanced Disease Lee M Ellis
Medical Oncologists Cathy Eng
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells The Clinical Utility of Circulating Tumor Cell Analysis: What Have We Learned So Far? Beverly C. Handy
August 21, 2009 Eighth International Congress on Targeted Therapies in Cancer Terminating the Cancer Cell (Cycle) Anas Younes
BiTes Anas Younes
June 9, 2009 Cell and Tissue-Based Assays for HTS A Novel Platform for High-Throughput Gene Expression Profiling Andreas Jeromin
June 8, 2009 RNAi for Functional Screens Towards Functional Annotation of the Cancer Genome Michael A. White
May 11, 2009 Patient Recruitment in Clinical Trials Interactive Open-Forum Format Melynda Geurts, Susan Campbell
Table #7: When Should a Risk Share Model Be Utilized? Melynda Geurts
February 17, 2009 Pharma/Biotech Patent Litigation Reviewing Recent US Judicial Decisions Thomas J. Kowalski
January 26, 2009 Biomarker Assay Development Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
January 26, 2009 Translational Cancer Medicine Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
November 17, 2008 Mastering Process Chemistry Control Strategy in a Quality by Design (QbD) Environment Stephen Liebowitz
November 17, 2008 BIO-Europe 2008 Critical Issues to Consider when Entering the U.S. Market and Partnering with U.S. Companies Steve Bryant
November 5, 2008 DIA's 6th Canadian Annual Meeting: Benefit and Risk Management: An Evolution in Progress TRACK 1 : USE OF IMAGING TO DETERMINE EFFICACY Gordon Mills
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Crystallographic Studies of CYP46A1 Irina A. Pikuleva
September 29, 2008 Biomarker Data Analysis Chairperson’s Opening Remarks George A. Calin
High-Throughput Functional Proteomics Facilitates a Systems Biology Approach to Personalized Medicine Gordon Mills
Semantic Web Abstractions for Biomedical Informatics: A Better Foundation for Integrating Sensitive Heterogeneous Data Sources Jonas S. Almeida
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 2: Etiology and Epidemiology of Viral Infections R. Palmer Beasley
Session 3: Epidemiology and Virology Lu-Yu Hwang
Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States Lu-Yu Hwang
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Morning Symposia 11: Allosteric Control and Conformational Changes Vincent Hilser
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
cancer genetics-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Single Nucleotide Polymorphisms, Clinical Trials, and Tobacco Research: Search for the Smoking Gun Margaret R. Spitz
cancer prevention/epidemiology-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
developmental therapeutics-- c-MET Inhibition for Cancer Treatment Razelle Kurzrock
developmental therapeutics-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
developmental therapeutics-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
gastrointestinal (colorectal) cancer-- Advances in Anal Cancer Management (M01) Cathy Eng
gastrointestinal (colorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
gastrointestinal (noncolorectal) cancer-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
gastrointestinal (noncolorectal) cancer-- Intraperitoneal Treatment for Gastrointestinal Cancer: Role of Debulking and Chemotherapy Cathy Eng
gastrointestinal (noncolorectal) cancer Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
genitourinary cancer-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies CPO20A) Paul Mathew
genitourinary cancer What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
gynecologic cancer-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
lung cancer-- Therapeutic Modalities for “Small” Stage I Lung Cancers Robert Timmerman
lymphoma and plasma cell disorders-- The Role of Maintenance Therapy in Follicular Lymphoma: Pros and Cons Peter McLaughlin
patient and survivor care-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
patient and survivor care-- Picking the Winners Through Biomarker Enrichment: Could This Be the End of Phase III Trials? Chris H. Takimoto
sarcoma/bone and soft tissue cancers-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
tumor biology-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
meet the professor sessions-- Advances in Anal Cancer Management (M01) Cathy Eng
meet the professor sessions-- Issues in the Modulation of Angiogenesis Pathways (M10) Roy S. Herbst
meet the professor sessions-- Practical Aspects of Intraperitoneal Chemotherapy Administration (M20) Maurie Markman
meet the professor sessions-- Postmenopausal Hormone Therapy: Friend or Foe? (M19) Peter Ravdin
meet the professor sessions-- Management of Soft Tissue Sarcoma for the Community Oncologist (M12) Shreyaskumar Patel
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07A) James C. Yao
clinical problems in oncology-- Management of Neuroendocrine Cancers: Radiopharmaceuticals, Novel Therapies, and the Impact of Octreotide (CPO07B) James C. Yao
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20A) Paul Mathew
clinical problems in oncology-- What to Do for the Prostate Cancer Patient with a Rising Prostate-Specific Antigen and No Disease on Imaging Studies (CPO20B) Paul Mathew
March 30, 2008 Metabolic Pathways of Longevity The Role of Nutrient Sensing in Aging II: Caloric Restriction Arlan G Richardson
Oxidative Stress, Aging, & Insulin/IGF1 Signaling Arlan G Richardson
March 30, 2008 Nuclear Receptors: Steroid Sisters Differentiation and Development David J. Mangelsdorf
Steroid Receptor Signaling and Dynamics Stephen R. Hammes
Steroid Receptors and Cancer Rakesh Kumar
Workshop 3 - Hot Topics: Chromatin/Transcription Raj Kumar
March 30, 2008 Nuclear Receptors: Orphan Brothers Differentiation and Development David J. Mangelsdorf
Steroid Receptor Signaling and Dynamics Stephen R. Hammes
Steroid Receptors and Cancer Rakesh Kumar
Workshop 3 - Hot Topics: Chromatin/Transcription Raj Kumar
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Monitoring and Manipulating the Proteome With Peptoids Thomas Kodadek
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Muhammad H. Zaman
Cellular Biology of Gap Junction Channels (Room 103A) Guillermo Altenberg, Srikanth Polusani
Translocon-mediated Head-First Insertion and Rotation of a Signal Anchor during Cotranslational Integration. A E Johnson
Mechanism of the Neurospora Circadian Negative Feedback Loop. Yi Liu
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) NUCLEAR HORMONE RECEPTORS (14:10-18:50) Carole R. Mendelson
NUCLEAR HORMONE RECEPTORS: Progesterone Receptor Modulation of Inflammatory Signaling in Pregnancy and Labor (17:20-17:50) Carole R. Mendelson
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.